​

Bolt Biotherapeutics Ownership | Who Owns Bolt Biotherapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Bolt Biotherapeutics Ownership Summary

Bolt Biotherapeutics is owned by 47.80% institutional investors, 2.26% insiders, and 49.94% retail investors. Tang capital management is the largest institutional shareholder, holding 9.97% of BOLT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.51% of its assets in Bolt Biotherapeutics shares.

BOLT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBolt Biotherapeutics47.80%2.26%49.94%
SectorHealthcare Stocks 279.19%10.58%-189.76%
IndustryBiotech Stocks 63.97%10.68%25.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tang capital management3.81M9.97%$2.04M
Vivo capital3.52M9.21%$1.88M
Sofinnova investments2.75M7.20%$1.47M
Citadel advisors2.37M6.22%$1.78M
Pivotal bioventure partners investment advisor1.89M4.94%$1.02M
Nan fung group1.17M3.05%$624.44K
Vanguard group1.07M2.79%$571.06K
Samsara biocapital1.05M2.74%$561.40K
Board of trustees of the leland stanford junior university719.55K1.88%$384.96K
Pfizer626.11K1.64%$335.03K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pivotal bioventure partners investment advisor1.89M0.69%$1.02M
Nan fung group1.17M0.53%$624.44K
Vivo capital3.52M0.21%$1.88M
Tang capital management3.81M0.14%$2.04M
Sofinnova investments2.75M0.11%$1.47M
Samsara biocapital1.05M0.08%$561.40K
Board of trustees of the leland stanford junior university719.55K0.03%$384.96K
Adar1 capital management244.97K0.03%$131.08K
Pfizer626.11K0.01%$335.03K
Xtx topco44.89K0.00%$24.02K

Top Buyers

HolderShares% AssetsChange
Pfizer626.11K0.01%626.11K
Squarepoint ops48.97K-48.97K
Xtx topco44.89K0.00%44.89K
Ubs group66.11K-30.82K
Fmr129.25K-13.87K

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---1.54M
Acuitas investments---630.51K
Adage capital partners gp---500.00K
Newtyn management---468.91K
Susquehanna group, llp---147.93K

New Positions

HolderShares% AssetsChangeValue
Pfizer626.11K0.01%626.11K$335.03K
Squarepoint ops48.97K-48.97K$26.20K
Xtx topco44.89K0.00%44.89K$24.02K

Sold Out

HolderChange
Bnp paribas arbitrage, snc-1.00
Qube research-2.00
Wells fargo & company/mn-211.00
Steward partners investment advisory-1.00K
Advisor group-17.36K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202528-24.32%18,325,858-1.84%472.01%10-41.18%5-
Dec 31, 20243719.35%18,670,034-0.60%482.02%1770.00%5-37.50%
Sep 30, 202431-11.43%18,782,187-16.99%491.39%10-37.50%833.33%
Jun 30, 202435-5.41%22,625,732-5.73%591.48%1660.00%6-45.45%
Mar 31, 202437-2.63%24,001,384-0.52%631.56%10-33.33%11-8.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv964.17K2.51%-
Vanguard US Total Market Shares ETF861.87K2.25%-1.00
Vanguard Institutional Extnd Mkt Idx Tr205.54K0.54%-
Fidelity Extended Market Index142.91K0.37%1.44K
Fidelity Total Market Index107.60K0.28%-
Fidelity Enhanced Small Cap ETF90.25K0.24%1.69K
iShares Micro-Cap ETF62.90K0.16%-
Bridgeway Ultra-Small Company Market60.20K0.16%-
Spartan Extended Market Index Pool E58.62K0.15%1.23K
Spartan Extended Market Index Pool F58.62K0.15%1.23K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 06, 2024Nemec Sarah Senior VP, Finance and PAOBuy$1.59K
Dec 16, 2024Nemec Sarah Senior VP, Finance and PAOBuy$1.24K
Jun 06, 2024Quinn William P. President, CEO and CFOBuy$1.59K
Dec 16, 2024Quinn William P. President, CEO and CFOBuy$1.24K
Jun 06, 2023Quinn William P. Chief Financial OfficerBuy$2.16K

Insider Transactions Trends

DateBuySell
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4224
2023 Q21-

BOLT Ownership FAQ

Who Owns Bolt Biotherapeutics?

Bolt Biotherapeutics shareholders are primarily institutional investors at 47.80%, followed by 2.26% insiders and 49.94% retail investors. The average institutional ownership in Bolt Biotherapeutics's industry, Biotech Stocks , is 63.97%, which Bolt Biotherapeutics falls below.

Who owns the most shares of Bolt Biotherapeutics?

Bolt Biotherapeutics’s largest shareholders are Tang capital management (3.81M shares, 9.97%), Vivo capital (3.52M shares, 9.21%), and Sofinnova investments (2.75M shares, 7.20%). Together, they hold 26.37% of Bolt Biotherapeutics’s total shares outstanding.

Does Blackrock own Bolt Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of Bolt Biotherapeutics.

Who is Bolt Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Pivotal bioventure partners investment advisor is Bolt Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 0.69% of its assets in 1.89M Bolt Biotherapeutics shares, valued at 1.02M$.

Who is the top mutual fund holder of Bolt Biotherapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Bolt Biotherapeutics shares, with 2.51% of its total shares outstanding invested in 964.17K Bolt Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools